Intrathecal Ketorolac in Patients With Intrathecal Morphine Dose Escalation

NCT00349401 · Status: WITHDRAWN · Phase: PHASE2 · Type: INTERVENTIONAL

Last updated 2017-11-06

No results posted yet for this study

Summary

The purpose of this study is to determine how the drug ketorolac, when given with the spinal morphine, affects pain.

Conditions

Interventions

DRUG

ketorolac

DRUG

morphine

Sponsors & Collaborators

  • Wake Forest University Health Sciences

    lead OTHER

Principal Investigators

  • James C. Eisenach, M.D. · Wake Forest University Health Sciences

  • Richard Rauck, M.D. · The Center for Clinical Research

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-12-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00349401 on ClinicalTrials.gov